MEGANet-W: A Wavelet-Driven Edge-Guided Attention Framework for Weak Boundary Polyp Detection

Colorectal polyp segmentation is critical for early detection of colorectal cancer, yet weak and low contrast boundaries significantly limit automated accuracy. Existing deep models either blur fine edge details or rely on handcrafted filters that perform poorly under variable imaging conditions. We propose MEGANet-W, a Wavelet Driven Edge Guided Attention Network that injects directional, parameter free Haar wavelet edge maps into each decoder stage to recalibrate semantic features. Our two main contributions are: (1) a two-level Haar wavelet head for multi orientation edge extraction; and (2) Wavelet Edge Guided Attention (WEGA) modules that fuse wavelet cues with reverse and input branches. On five public polyp datasets, MEGANetW consistently outperforms existing methods, improving mIoU by up to 2.3% and mDice by 1.2%, while introducing no additional learnable parameters.

Detecting malignant dynamics on very few blood sample using signature coefficients

Recent discoveries have suggested that the promising avenue of using circulating tumor DNA (ctDNA) levels in blood samples provides reasonable accuracy for cancer monitoring, with extremely low burden on the patient's side. It is known that the presence of ctDNA can result from various mechanisms leading to DNA release from cells, such as apoptosis, necrosis or active secretion. One key idea in recent cancer monitoring studies is that monitoring the dynamics of ctDNA levels might be sufficient for early multi-cancer detection. This interesting idea has been turned into commercial products, e.g. in the company named GRAIL. In the present work, we propose to explore the use of Signature theory for detecting aggressive cancer tumors based on the analysis of blood samples. Our approach combines tools from continuous time Markov modelling for the dynamics of ctDNA levels in the blood, with Signature theory for building efficient testing procedures. Signature theory is a topic of growing interest in the Machine Learning community (see Chevyrev2016 and Fermanian2021), which is now recognised as a powerful feature extraction tool for irregularly sampled signals. The method proposed in the present paper is shown to correctly address the challenging problem of overcoming the inherent data scarsity due to the extremely small number of blood samples per patient. The relevance of our approach is illustrated with extensive numerical experiments that confirm the efficiency of the proposed pipeline.

Integrating Complexity and Biological Realism: High-Performance Spiking Neural Networks for Breast Cancer Detection

Spiking Neural Networks (SNNs) event-driven nature enables efficient encoding of spatial and temporal features, making them suitable for dynamic time-dependent data processing. Despite their biological relevance, SNNs have seen limited application in medical image recognition due to difficulties in matching the performance of conventional deep learning models. To address this, we propose a novel breast cancer classification approach that combines SNNs with Lempel-Ziv Complexity (LZC) a computationally efficient measure of sequence complexity. LZC enhances the interpretability and accuracy of spike-based models by capturing structural patterns in neural activity. Our study explores both biophysical Leaky Integrate-and-Fire (LIF) and probabilistic Levy-Baxter (LB) neuron models under supervised, unsupervised, and hybrid learning regimes. Experiments were conducted on the Breast Cancer Wisconsin dataset using numerical features derived from medical imaging. LB-based models consistently exceeded 90.00% accuracy, while LIF-based models reached over 85.00%. The highest accuracy of 98.25% was achieved using an ANN-to-SNN conversion method applied to both neuron models comparable to traditional deep learning with back-propagation, but at up to 100 times lower computational cost. This hybrid approach merges deep learning performance with the efficiency and plausibility of SNNs, yielding top results at lower computational cost. We hypothesize that the synergy between temporal-coding, spike-sparsity, and LZC-driven complexity analysis enables more-efficient feature extraction. Our findings demonstrate that SNNs combined with LZC offer promising, biologically plausible alternative to conventional neural networks in medical diagnostics, particularly for resource-constrained or real-time systems.

An Artificial Intelligence Model for Early Stage Breast Cancer Detection from Biopsy Images

Accurate identification of breast cancer types plays a critical role in guiding treatment decisions and improving patient outcomes. This paper presents an artificial intelligence enabled tool designed to aid in the identification of breast cancer types using histopathological biopsy images. Traditionally additional tests have to be done on women who are detected with breast cancer to find out the types of cancer it is to give the necessary cure. Those tests are not only invasive but also delay the initiation of treatment and increase patient burden. The proposed model utilizes a convolutional neural network (CNN) architecture to distinguish between benign and malignant tissues as well as accurate subclassification of breast cancer types. By preprocessing the images to reduce noise and enhance features, the model achieves reliable levels of classification performance. Experimental results on such datasets demonstrate the model's effectiveness, outperforming several existing solutions in terms of accuracy, precision, recall, and F1-score. The study emphasizes the potential of deep learning techniques in clinical diagnostics and offers a promising tool to assist pathologists in breast cancer classification.

Deep Learning for Breast Cancer Detection: Comparative Analysis of ConvNeXT and EfficientNet

Breast cancer is the most commonly occurring cancer worldwide. This cancer caused 670,000 deaths globally in 2022, as reported by the WHO. Yet since health officials began routine mammography screening in age groups deemed at risk in the 1980s, breast cancer mortality has decreased by 40% in high-income nations. Every day, a greater and greater number of people are receiving a breast cancer diagnosis. Reducing cancer-related deaths requires early detection and treatment. This paper compares two convolutional neural networks called ConvNeXT and EfficientNet to predict the likelihood of cancer in mammograms from screening exams. Preprocessing of the images, classification, and performance evaluation are main parts of the whole procedure. Several evaluation metrics were used to compare and evaluate the performance of the models. The result shows that ConvNeXT generates better results with a 94.33% AUC score, 93.36% accuracy, and 95.13% F-score compared to EfficientNet with a 92.34% AUC score, 91.47% accuracy, and 93.06% F-score on RSNA screening mammography breast cancer dataset.

Mamba Guided Boundary Prior Matters: A New Perspective for Generalized Polyp Segmentation

Polyp segmentation in colonoscopy images is crucial for early detection and diagnosis of colorectal cancer. However, this task remains a significant challenge due to the substantial variations in polyp shape, size, and color, as well as the high similarity between polyps and surrounding tissues, often compounded by indistinct boundaries. While existing encoder-decoder CNN and transformer-based approaches have shown promising results, they struggle with stable segmentation performance on polyps with weak or blurry boundaries. These methods exhibit limited abilities to distinguish between polyps and non-polyps and capture essential boundary cues. Moreover, their generalizability still falls short of meeting the demands of real-time clinical applications. To address these limitations, we propose SAM-MaGuP, a groundbreaking approach for robust polyp segmentation. By incorporating a boundary distillation module and a 1D-2D Mamba adapter within the Segment Anything Model (SAM), SAM-MaGuP excels at resolving weak boundary challenges and amplifies feature learning through enriched global contextual interactions. Extensive evaluations across five diverse datasets reveal that SAM-MaGuP outperforms state-of-the-art methods, achieving unmatched segmentation accuracy and robustness. Our key innovations, a Mamba-guided boundary prior and a 1D-2D Mamba block, set a new benchmark in the field, pushing the boundaries of polyp segmentation to new heights.

Bluish Veil Detection and Lesion Classification using Custom Deep Learnable Layers with Explainable Artificial Intelligence (XAI)

Melanoma, one of the deadliest types of skin cancer, accounts for thousands of fatalities globally. The bluish, blue-whitish, or blue-white veil (BWV) is a critical feature for diagnosing melanoma, yet research into detecting BWV in dermatological images is limited. This study utilizes a non-annotated skin lesion dataset, which is converted into an annotated dataset using a proposed imaging algorithm based on color threshold techniques on lesion patches and color palettes. A Deep Convolutional Neural Network (DCNN) is designed and trained separately on three individual and combined dermoscopic datasets, using custom layers instead of standard activation function layers. The model is developed to categorize skin lesions based on the presence of BWV. The proposed DCNN demonstrates superior performance compared to conventional BWV detection models across different datasets. The model achieves a testing accuracy of 85.71% on the augmented PH2 dataset, 95.00% on the augmented ISIC archive dataset, 95.05% on the combined augmented (PH2+ISIC archive) dataset, and 90.00% on the Derm7pt dataset. An explainable artificial intelligence (XAI) algorithm is subsequently applied to interpret the DCNN's decision-making process regarding BWV detection. The proposed approach, coupled with XAI, significantly improves the detection of BWV in skin lesions, outperforming existing models and providing a robust tool for early melanoma diagnosis.

Mammo-Mamba: A Hybrid State-Space and Transformer Architecture with Sequential Mixture of Experts for Multi-View Mammography

Breast cancer (BC) remains one of the leading causes of cancer-related mortality among women, despite recent advances in Computer-Aided Diagnosis (CAD) systems. Accurate and efficient interpretation of multi-view mammograms is essential for early detection, driving a surge of interest in Artificial Intelligence (AI)-powered CAD models. While state-of-the-art multi-view mammogram classification models are largely based on Transformer architectures, their computational complexity scales quadratically with the number of image patches, highlighting the need for more efficient alternatives. To address this challenge, we propose Mammo-Mamba, a novel framework that integrates Selective State-Space Models (SSMs), transformer-based attention, and expert-driven feature refinement into a unified architecture. Mammo-Mamba extends the MambaVision backbone by introducing the Sequential Mixture of Experts (SeqMoE) mechanism through its customized SecMamba block. The SecMamba is a modified MambaVision block that enhances representation learning in high-resolution mammographic images by enabling content-adaptive feature refinement. These blocks are integrated into the deeper stages of MambaVision, allowing the model to progressively adjust feature emphasis through dynamic expert gating, effectively mitigating the limitations of traditional Transformer models. Evaluated on the CBIS-DDSM benchmark dataset, Mammo-Mamba achieves superior classification performance across all key metrics while maintaining computational efficiency.

Explainability Through Human-Centric Design for XAI in Lung Cancer Detection

Deep learning models have shown promise in lung pathology detection from chest X-rays, but widespread clinical adoption remains limited due to opaque model decision-making. In prior work, we introduced ClinicXAI, a human-centric, expert-guided concept bottleneck model (CBM) designed for interpretable lung cancer diagnosis. We now extend that approach and present XpertXAI, a generalizable expert-driven model that preserves human-interpretable clinical concepts while scaling to detect multiple lung pathologies. Using a high-performing InceptionV3-based classifier and a public dataset of chest X-rays with radiology reports, we compare XpertXAI against leading post-hoc explainability methods and an unsupervised CBM, XCBs. We assess explanations through comparison with expert radiologist annotations and medical ground truth. Although XpertXAI is trained for multiple pathologies, our expert validation focuses on lung cancer. We find that existing techniques frequently fail to produce clinically meaningful explanations, omitting key diagnostic features and disagreeing with radiologist judgments. XpertXAI not only outperforms these baselines in predictive accuracy but also delivers concept-level explanations that better align with expert reasoning. While our focus remains on explainability in lung cancer detection, this work illustrates how human-centric model design can be effectively extended to broader diagnostic contexts - offering a scalable path toward clinically meaningful explainable AI in medical diagnostics.

A Cytology Dataset for Early Detection of Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma OSCC is a major global health burden, particularly in several regions across Asia, Africa, and South America, where it accounts for a significant proportion of cancer cases. Early detection dramatically improves outcomes, with stage I cancers achieving up to 90 percent survival. However, traditional diagnosis based on histopathology has limited accessibility in low-resource settings because it is invasive, resource-intensive, and reliant on expert pathologists. On the other hand, oral cytology of brush biopsy offers a minimally invasive and lower cost alternative, provided that the remaining challenges, inter observer variability and unavailability of expert pathologists can be addressed using artificial intelligence. Development and validation of robust AI solutions requires access to large, labeled, and multi-source datasets to train high capacity models that generalize across domain shifts. We introduce the first large and multicenter oral cytology dataset, comprising annotated slides stained with Papanicolaou(PAP) and May-Grunwald-Giemsa(MGG) protocols, collected from ten tertiary medical centers in India. The dataset is labeled and annotated by expert pathologists for cellular anomaly classification and detection, is designed to advance AI driven diagnostic methods. By filling the gap in publicly available oral cytology datasets, this resource aims to enhance automated detection, reduce diagnostic errors, and improve early OSCC diagnosis in resource-constrained settings, ultimately contributing to reduced mortality and better patient outcomes worldwide.